Home › NDC Lookup › RxCUI directory › RxCUI 1927672

Delafloxacin 300 MG Injection [Baxdela] — RxCUI 1927672

RxNorm drug concept · Semantic branded drug
RxCUI 1927672 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1927672
Official nameDelafloxacin 300 MG Injection [Baxdela]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBaxdela 300 MG Injection; Baxdela 300 MG (as delafloxacin meglumine 433 MG) Injection
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)12 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Delafloxacin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Baxdela is a prescription antibiotic used in adults to treat two specific types of bacterial infections: serious skin infections (called acute bacterial skin and skin structure inf...
  • Good news — you can take the Baxdela tablet with or without food, so meals aren't a concern. What you do need to watch out for is timing with certain other products: antacids with...
  • Can I take the tablet with food, and what should I avoid taking it with?
  • The most common side effects are nausea, diarrhea, headache, and vomiting — uncomfortable but usually manageable. What you need to stop the medication for immediately and call your...
📖 Read our full Delafloxacin guide →

🕸️ Concept Web — How Delafloxacin 300 MG Injection [Baxdela] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Delafloxacin 300 MG Injection [Baxdela] RxCUI 1927672

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Delafloxacin 1927663
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Baxdela 1927668
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Delafloxacin Injection 1927666
    • Delafloxacin Injectable Product 1927665
    • Delafloxacin Injection [Baxdela] 1927670
    • Baxdela Injectable Product 1927671
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Delafloxacin 300 MG Injection SCD · 1927667
  • Delafloxacin 300 MG SCDC · 1927664
  • Delafloxacin Injection SCDF · 1927666
  • Delafloxacin Injectable Product SCDG · 1927665

Brand-Name Concepts

  • Delafloxacin 300 MG [Baxdela] SBDC · 1927669
  • Delafloxacin Injection [Baxdela] SBDF · 1927670
  • Baxdela Injectable Product SBDG · 1927671
  • Baxdela BN · 1927668

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 1927672 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70842-0101-01 1 BOTTLE in 1 CARTON (70842-101-01) / 20 TABLET in 1 BOTTLE Baxdela Melinta Therapeutics, LLC 2017-06-19
70842-0101-02 2 BLISTER PACK in 1 CARTON (70842-101-02) / 10 TABLET in 1... Baxdela Melinta Therapeutics, LLC 2017-06-19
70842-0101-05 1 BLISTER PACK in 1 CARTON (70842-101-05) / 2 TABLET in 1 B... Baxdela Melinta Therapeutics, LLC 2018-05-09
70842-0102-03 10 VIAL, GLASS in 1 CARTON (70842-102-03) / 10.5 mL in 1 VI... Baxdela Melinta Therapeutics, LLC 2017-06-19
Observed labelers: Melinta Therapeutics, LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.